APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fluoxetine Hydrochloride (Prozac)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fluoxetine Hydrochloride (Prozac) Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchFluoxetine Hydrochloride (Prozac) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Fluoxetine Hydrochloride (Prozac) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Fluoxetine Hydrochloride (Prozac) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fluoxetine Hydrochloride (Prozac) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Fluoxetine Hydrochloride (Prozac) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Fluoxetine Hydrochloride (Prozac) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fluoxetine Hydrochloride (Prozac) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fluoxetine Hydrochloride (Prozac) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fluoxetine Hydrochloride (Prozac) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fluoxetine Hydrochloride (Prozac) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fluoxetine Hydrochloride (Prozac) market include Alembic Pharmaceuticals, Alvogen, Aurobindo Pharma, Changzhou Siyao Pharmaceutical, Dr.Reddy's Laboratories, Lannett Company, Pharmaceutical Associates Inc., Suzhou YUSHI Pharmaceutical and Torrent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fluoxetine Hydrochloride (Prozac) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fluoxetine Hydrochloride (Prozac) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fluoxetine Hydrochloride (Prozac) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fluoxetine Hydrochloride (Prozac) market size, projected growth trends, production technologies, key applications, and end-use industries.

Fluoxetine Hydrochloride (Prozac) Segment by Company

Alembic Pharmaceuticals

Alvogen

Aurobindo Pharma

Changzhou Siyao Pharmaceutical

Dr.Reddy's Laboratories

Lannett Company

Pharmaceutical Associates Inc.

Suzhou YUSHI Pharmaceutical

Torrent Pharmaceuticals

Wockhardt

Mylan

Sandoz

Sun Pharmaceutical

Teva

Fluoxetine Hydrochloride (Prozac) Segment by Type

Tablets

Capsules

Fluoxetine Hydrochloride (Prozac) Segment by Application

Panic Disorder

Obsessive-Compulsive Disorder

Bulimia Nervosa

Depression

Others

Fluoxetine Hydrochloride (Prozac) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Fluoxetine Hydrochloride (Prozac) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fluoxetine Hydrochloride (Prozac) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fluoxetine Hydrochloride (Prozac) significant trends, drivers, influence factors in global and regions.

6. To analyze Fluoxetine Hydrochloride (Prozac) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fluoxetine Hydrochloride (Prozac) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fluoxetine Hydrochloride (Prozac) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fluoxetine Hydrochloride (Prozac).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fluoxetine Hydrochloride (Prozac) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fluoxetine Hydrochloride (Prozac) industry.

Chapter 3: Detailed analysis of Fluoxetine Hydrochloride (Prozac) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fluoxetine Hydrochloride (Prozac) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fluoxetine Hydrochloride (Prozac) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fluoxetine Hydrochloride (Prozac) Industry Trends Table 2. Fluoxetine Hydrochloride (Prozac) Industry Drivers Table 3. Fluoxetine Hydrochloride (Prozac) Industry Opportunities and Challenges Table 4. Fluoxetine Hydrochloride (Prozac) Industry Restraints Table 5. Global Fluoxetine Hydrochloride (Prozac) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fluoxetine Hydrochloride (Prozac) Revenue Share by Company (2021-2026) Table 7. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Company (2021-2026) Table 9. Global Fluoxetine Hydrochloride (Prozac) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Fluoxetine Hydrochloride (Prozac) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fluoxetine Hydrochloride (Prozac) Key Company Manufacturing Base & Headquarters Table 12. Global Fluoxetine Hydrochloride (Prozac) Company, Product Type & Application Table 13. Global Fluoxetine Hydrochloride (Prozac) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fluoxetine Hydrochloride (Prozac) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Capsules Table 19. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Type (2021-2026) Table 23. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Type (2027-2032) Table 24. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type (2021-2026) Table 28. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Panic Disorder Table 30. Significant Companies of Obsessive-Compulsive Disorder Table 31. Significant Companies of Bulimia Nervosa Table 32. Significant Companies of Depression Table 33. Significant Companies of Others Table 34. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Application (2021-2026) Table 38. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Application (2027-2032) Table 39. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application (2021-2026) Table 43. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application (2027-2032) Table 44. Global Fluoxetine Hydrochloride (Prozac) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Fluoxetine Hydrochloride (Prozac) Sales by Region (2021-2026) & (K Units) Table 46. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share by Region (2021-2026) Table 47. Global Fluoxetine Hydrochloride (Prozac) Sales by Region (2027-2032) & (K Units) Table 48. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share by Region (2027-2032) Table 49. Global Fluoxetine Hydrochloride (Prozac) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Region (2021-2026) Table 52. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Region (2027-2032) Table 54. Global Fluoxetine Hydrochloride (Prozac) Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Fluoxetine Hydrochloride (Prozac) Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Fluoxetine Hydrochloride (Prozac) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Fluoxetine Hydrochloride (Prozac) Sales by Country (2021-2026) & (K Units) Table 59. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share by Country (2021-2026) Table 60. Global Fluoxetine Hydrochloride (Prozac) Sales by Country (2027-2032) & (K Units) Table 61. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share by Country (2027-2032) Table 62. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Fluoxetine Hydrochloride (Prozac) Sales Value Market Share by Country (2021-2026) Table 64. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Fluoxetine Hydrochloride (Prozac) Sales Value Market Share by Country (2027-2032) Table 66. Alembic Pharmaceuticals Company Information Table 67. Alembic Pharmaceuticals Business Overview Table 68. Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 70. Alembic Pharmaceuticals Recent Development Table 71. Alvogen Company Information Table 72. Alvogen Business Overview Table 73. Alvogen Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Alvogen Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 75. Alvogen Recent Development Table 76. Aurobindo Pharma Company Information Table 77. Aurobindo Pharma Business Overview Table 78. Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 80. Aurobindo Pharma Recent Development Table 81. Changzhou Siyao Pharmaceutical Company Information Table 82. Changzhou Siyao Pharmaceutical Business Overview Table 83. Changzhou Siyao Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Changzhou Siyao Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 85. Changzhou Siyao Pharmaceutical Recent Development Table 86. Dr.Reddy's Laboratories Company Information Table 87. Dr.Reddy's Laboratories Business Overview Table 88. Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 90. Dr.Reddy's Laboratories Recent Development Table 91. Lannett Company Company Information Table 92. Lannett Company Business Overview Table 93. Lannett Company Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Lannett Company Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 95. Lannett Company Recent Development Table 96. Pharmaceutical Associates Inc. Company Information Table 97. Pharmaceutical Associates Inc. Business Overview Table 98. Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 100. Pharmaceutical Associates Inc. Recent Development Table 101. Suzhou YUSHI Pharmaceutical Company Information Table 102. Suzhou YUSHI Pharmaceutical Business Overview Table 103. Suzhou YUSHI Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Suzhou YUSHI Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 105. Suzhou YUSHI Pharmaceutical Recent Development Table 106. Torrent Pharmaceuticals Company Information Table 107. Torrent Pharmaceuticals Business Overview Table 108. Torrent Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Torrent Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 110. Torrent Pharmaceuticals Recent Development Table 111. Wockhardt Company Information Table 112. Wockhardt Business Overview Table 113. Wockhardt Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Wockhardt Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 115. Wockhardt Recent Development Table 116. Mylan Company Information Table 117. Mylan Business Overview Table 118. Mylan Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Mylan Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 120. Mylan Recent Development Table 121. Sandoz Company Information Table 122. Sandoz Business Overview Table 123. Sandoz Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sandoz Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 125. Sandoz Recent Development Table 126. Sun Pharmaceutical Company Information Table 127. Sun Pharmaceutical Business Overview Table 128. Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 130. Sun Pharmaceutical Recent Development Table 131. Teva Company Information Table 132. Teva Business Overview Table 133. Teva Fluoxetine Hydrochloride (Prozac) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Teva Fluoxetine Hydrochloride (Prozac) Product Portfolio Table 135. Teva Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Fluoxetine Hydrochloride (Prozac) Distributors List Table 139. Fluoxetine Hydrochloride (Prozac) Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Fluoxetine Hydrochloride (Prozac) Product Image Figure 2. Global Fluoxetine Hydrochloride (Prozac) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fluoxetine Hydrochloride (Prozac) Sales (2021-2032) & (K Units) Figure 5. Global Fluoxetine Hydrochloride (Prozac) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Fluoxetine Hydrochloride (Prozac) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Type (2021-2032) Figure 14. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type (2021-2032) Figure 17. Panic Disorder Image Figure 18. Obsessive-Compulsive Disorder Image Figure 19. Bulimia Nervosa Image Figure 20. Depression Image Figure 21. Others Image Figure 22. Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Application (2021-2032) Figure 25. Global Fluoxetine Hydrochloride (Prozac) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application (2021-2032) Figure 28. Global Fluoxetine Hydrochloride (Prozac) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Fluoxetine Hydrochloride (Prozac) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Fluoxetine Hydrochloride (Prozac) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Fluoxetine Hydrochloride (Prozac) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Fluoxetine Hydrochloride (Prozac) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Panic Disorder
  • Obsessive-Compulsive Disorder
  • Bulimia Nervosa
  • Depression
  • Others
Companies covered
  • Alembic Pharmaceuticals
  • Alvogen
  • Aurobindo Pharma
  • Changzhou Siyao Pharmaceutical
  • Dr.Reddy's Laboratories
  • Lannett Company
  • Pharmaceutical Associates Inc.
  • Suzhou YUSHI Pharmaceutical
  • Torrent Pharmaceuticals
  • Wockhardt
  • Mylan
  • Sandoz
  • Sun Pharmaceutical
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032)
  4. 1.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales Volume (2021-2032)
  5. 1.2.3 Global Fluoxetine Hydrochloride (Prozac) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fluoxetine Hydrochloride (Prozac) Market Dynamics
  1. 2.1 Fluoxetine Hydrochloride (Prozac) Industry Trends
  2. 2.2 Fluoxetine Hydrochloride (Prozac) Industry Drivers
  3. 2.3 Fluoxetine Hydrochloride (Prozac) Industry Opportunities and Challenges
  4. 2.4 Fluoxetine Hydrochloride (Prozac) Industry Restraints
3 Fluoxetine Hydrochloride (Prozac) Market by Company
  1. 3.1 Global Fluoxetine Hydrochloride (Prozac) Company Revenue Ranking in 2025
  2. 3.2 Global Fluoxetine Hydrochloride (Prozac) Revenue by Company (2021-2026)
  3. 3.3 Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Company (2021-2026)
  4. 3.4 Global Fluoxetine Hydrochloride (Prozac) Average Price by Company (2021-2026)
  5. 3.5 Global Fluoxetine Hydrochloride (Prozac) Company Ranking (2024-2026)
  6. 3.6 Global Fluoxetine Hydrochloride (Prozac) Company Manufacturing Base and Headquarters
  7. 3.7 Global Fluoxetine Hydrochloride (Prozac) Company Product Type and Application
  8. 3.8 Global Fluoxetine Hydrochloride (Prozac) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fluoxetine Hydrochloride (Prozac) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fluoxetine Hydrochloride (Prozac) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fluoxetine Hydrochloride (Prozac) Market by Type
  1. 4.1 Fluoxetine Hydrochloride (Prozac) Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Type
  5. 4.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Type
  9. 4.3.1 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type (2021-2032)
5 Fluoxetine Hydrochloride (Prozac) Market by Application
  1. 5.1 Fluoxetine Hydrochloride (Prozac) Application Introduction
  2. 5.1.1 Panic Disorder
  3. 5.1.2 Obsessive-Compulsive Disorder
  4. 5.1.3 Bulimia Nervosa
  5. 5.1.4 Depression
  6. 5.1.5 Others
  7. 5.2 Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Application
  8. 5.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Fluoxetine Hydrochloride (Prozac) Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Application
  12. 5.3.1 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Application (2021-2032)
  14. 5.3.3 Global Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application (2021-2032)
6 Fluoxetine Hydrochloride (Prozac) Regional Sales and Value Analysis
  1. 6.1 Global Fluoxetine Hydrochloride (Prozac) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Region (2021-2032)
  3. 6.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales by Region: 2021-2026
  4. 6.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Region (2027-2032)
  5. 6.3 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Region (2027-2032)
  9. 6.5 Global Fluoxetine Hydrochloride (Prozac) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032)
  12. 6.6.2 North America Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032)
  15. 6.7.2 Europe Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032)
  21. 6.9.2 South America Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fluoxetine Hydrochloride (Prozac) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fluoxetine Hydrochloride (Prozac) Sales Value Share by Country, 2025 VS 2032
7 Fluoxetine Hydrochloride (Prozac) Country-level Sales and Value Analysis
  1. 7.1 Global Fluoxetine Hydrochloride (Prozac) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fluoxetine Hydrochloride (Prozac) Sales by Country (2021-2032)
  4. 7.3.1 Global Fluoxetine Hydrochloride (Prozac) Sales by Country (2021-2026)
  5. 7.3.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Country (2027-2032)
  6. 7.4 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fluoxetine Hydrochloride (Prozac) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fluoxetine Hydrochloride (Prozac) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fluoxetine Hydrochloride (Prozac) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fluoxetine Hydrochloride (Prozac) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic Pharmaceuticals
  2. 8.1.1 Alembic Pharmaceuticals Company Information
  3. 8.1.2 Alembic Pharmaceuticals Business Overview
  4. 8.1.3 Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Product Portfolio
  6. 8.1.5 Alembic Pharmaceuticals Recent Developments
  7. 8.2 Alvogen
  8. 8.2.1 Alvogen Company Information
  9. 8.2.2 Alvogen Business Overview
  10. 8.2.3 Alvogen Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Alvogen Fluoxetine Hydrochloride (Prozac) Product Portfolio
  12. 8.2.5 Alvogen Recent Developments
  13. 8.3 Aurobindo Pharma
  14. 8.3.1 Aurobindo Pharma Company Information
  15. 8.3.2 Aurobindo Pharma Business Overview
  16. 8.3.3 Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Product Portfolio
  18. 8.3.5 Aurobindo Pharma Recent Developments
  19. 8.4 Changzhou Siyao Pharmaceutical
  20. 8.4.1 Changzhou Siyao Pharmaceutical Company Information
  21. 8.4.2 Changzhou Siyao Pharmaceutical Business Overview
  22. 8.4.3 Changzhou Siyao Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Changzhou Siyao Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio
  24. 8.4.5 Changzhou Siyao Pharmaceutical Recent Developments
  25. 8.5 Dr.Reddy's Laboratories
  26. 8.5.1 Dr.Reddy's Laboratories Company Information
  27. 8.5.2 Dr.Reddy's Laboratories Business Overview
  28. 8.5.3 Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Product Portfolio
  30. 8.5.5 Dr.Reddy's Laboratories Recent Developments
  31. 8.6 Lannett Company
  32. 8.6.1 Lannett Company Company Information
  33. 8.6.2 Lannett Company Business Overview
  34. 8.6.3 Lannett Company Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lannett Company Fluoxetine Hydrochloride (Prozac) Product Portfolio
  36. 8.6.5 Lannett Company Recent Developments
  37. 8.7 Pharmaceutical Associates Inc.
  38. 8.7.1 Pharmaceutical Associates Inc. Company Information
  39. 8.7.2 Pharmaceutical Associates Inc. Business Overview
  40. 8.7.3 Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Product Portfolio
  42. 8.7.5 Pharmaceutical Associates Inc. Recent Developments
  43. 8.8 Suzhou YUSHI Pharmaceutical
  44. 8.8.1 Suzhou YUSHI Pharmaceutical Company Information
  45. 8.8.2 Suzhou YUSHI Pharmaceutical Business Overview
  46. 8.8.3 Suzhou YUSHI Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Suzhou YUSHI Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio
  48. 8.8.5 Suzhou YUSHI Pharmaceutical Recent Developments
  49. 8.9 Torrent Pharmaceuticals
  50. 8.9.1 Torrent Pharmaceuticals Company Information
  51. 8.9.2 Torrent Pharmaceuticals Business Overview
  52. 8.9.3 Torrent Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Torrent Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Product Portfolio
  54. 8.9.5 Torrent Pharmaceuticals Recent Developments
  55. 8.10 Wockhardt
  56. 8.10.1 Wockhardt Company Information
  57. 8.10.2 Wockhardt Business Overview
  58. 8.10.3 Wockhardt Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Wockhardt Fluoxetine Hydrochloride (Prozac) Product Portfolio
  60. 8.10.5 Wockhardt Recent Developments
  61. 8.11 Mylan
  62. 8.11.1 Mylan Company Information
  63. 8.11.2 Mylan Business Overview
  64. 8.11.3 Mylan Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Mylan Fluoxetine Hydrochloride (Prozac) Product Portfolio
  66. 8.11.5 Mylan Recent Developments
  67. 8.12 Sandoz
  68. 8.12.1 Sandoz Company Information
  69. 8.12.2 Sandoz Business Overview
  70. 8.12.3 Sandoz Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sandoz Fluoxetine Hydrochloride (Prozac) Product Portfolio
  72. 8.12.5 Sandoz Recent Developments
  73. 8.13 Sun Pharmaceutical
  74. 8.13.1 Sun Pharmaceutical Company Information
  75. 8.13.2 Sun Pharmaceutical Business Overview
  76. 8.13.3 Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio
  78. 8.13.5 Sun Pharmaceutical Recent Developments
  79. 8.14 Teva
  80. 8.14.1 Teva Company Information
  81. 8.14.2 Teva Business Overview
  82. 8.14.3 Teva Fluoxetine Hydrochloride (Prozac) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Teva Fluoxetine Hydrochloride (Prozac) Product Portfolio
  84. 8.14.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fluoxetine Hydrochloride (Prozac) Value Chain Analysis
  2. 9.1.1 Fluoxetine Hydrochloride (Prozac) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fluoxetine Hydrochloride (Prozac) Sales Mode & Process
  6. 9.2 Fluoxetine Hydrochloride (Prozac) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fluoxetine Hydrochloride (Prozac) Distributors
  9. 9.2.3 Fluoxetine Hydrochloride (Prozac) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst